Replies to post #28387 on Rebus Holdings Inc (RBSH)

[EBW31]

I am here for the cancer Med
Brother passed away in January from brain cancer
diagnosed in October
No good cures
NSPX may have part of the answer
"Inspyr Therapeutics, Inc. develops therapies for cancer using a novel technology platform that combines a powerful therapeutic (thapsigargin) with a patented prodrug delivery system that targets the release of drugs within solid tumors. Mipsagargin, its lead drug candidate, has been studied in a Phase 2 clinical trial in patients with Nexavar-refractory hepatocellular carcinoma (HCC) and has been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in this indication."
Not blaming shorts for anything
I just don't want new people to read that BS everyday thinking this stock has no future.
I am long
I am loaded
will load more if it drops lower
this will run again
there will be a deal made
mark it
IMHO

[flaflyersfan]

Condors rugby, NSPX patents are not valuable;

NSPX values all of their Intellectual Property at $20,000. Please read this entire document;

https://www.sec.gov/Archives/edgar/data/1421204/000121390019026668/f10q0919_inspyrtherapeutics.htm

Good luck.